Biopsy and Re-biopsy of the Prostate: Interview with E. David Crawford, MD
Watch an interview between Dr. Crawford and Dr. Thomas Keane about when to biopsy and when to rebiopsy a patient with prostate cancer or...
Prostate cancer: incorporating genomic biomarkers in prostate cancer decisions
Read an article from Dr. Crawford from Clinical Perspective to learn which genomic biomarkers are most useful in prostate cancer. Click...
What are Currently the Best Decision Markers for Biopsy and Re-biopsy of the Prostate?
Watch an interview from UroToday of Dr. Crawford discussing which markers are best in the decision when and if a prostate biopsy or...
Promising Biomarkers Emerging Across the Spectrum of Prostate Cancer Care
Dr. Crawford discusses the latest and greatest biomarkers and their utility in diagnosing and treating prostate cancer Click here to...
Best Paper: CancerNetwork.com
Dr. Crawford's paper on biomarkers awarded best paper in CancerNetwork. Click here to learn more #photo
Hospital Shows Key to Fighting Prostate Cancer Is Finding It
The University of Colorado discusses Dr. Crawford's role in accurately diagnosing prostate cancer through 3 Dimensional Mapping Biopsy....
In Treating Prostate Cancer, Choices for Patients, Challenges for Clincians, Payers
Dr. Crawford discusses the United States Preventive Services Task Force (USPSTF) recommendation against PSA screening. Click here to...
Prostate Cancer Isn’t a Coffee Drinker
Dr. Crawford discusses how patients who drank more coffee had lower prostate cancer recurrence rates. Click here to learn more #photo
Okay to Go Slow with Prostate Cancer, a Slow Growing Cancer
Dr. Crawford discusses active surveillance vs surgery for prostate cancer. Click here to learn more #photo
Hold Your Horses, Older Men!
Dr. Crawford discusses how older men are less susceptible to die of prostate cancer. Click here to learn more #photo
